ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Suggested protocol for monitoring urinary tract disease in patients with myelomeningocele

Suggested protocol for monitoring urinary tract disease in patients with myelomeningocele
  Bladder and renal ultrasound VCUG* CMG and EMG*
Purpose
  Detect hydronephrosis, hydroureter, assess bladder wall thickness Detect vesicoureteral reflux, measure bladder capacity and postresidual volume Assess bladder pressure, bladder capacity, urine flow rate, sphincter activity, and bladder emptying
Age
Birth    
3 to 4 months
6 months    
9 months    
12 months
18 months    
24 months    
3 years
Every year thereafter    
Every 2 to 3 years thereafter  
This table summarizes our general approach to urinary tract monitoring in patients with myelomeningocele. VCUG, CMG, and EMG* should be performed more frequently if there is a change in urinary continence, changes in ultrasound findings (eg, hydronephrosis), or recurrent urinary tract infections. Changes in lower urinary tract function may be an early sign of spinal cord tethering. For further details, refer to UpToDate's topic on urinary tract complications of myelomeningocele.

VCUG: voiding cystourethrogram; CMG: cystometrogram; EMG: electromyogram.

* Ideally, VCUG, CMG, and EMG are performed at the same time, in the form of a video-urodynamic study.
Modified from: Tarcan T, Bauer S, Olmedo E, et al. Long-term follow-up of newborns with myelodysplasia and normal urodynamic findings: Is follow-up necessary? J Urol 2001; 165:564.
Graphic 52561 Version 7.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟